ASTELLAS PHARMA A/S
CVR 10888638 · Public limited company (A/S) · Active · Low risk
ASTELLAS PHARMA A/S is a Public limited company (A/S), founded on , based in København S. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 20.1m and a net result of DKK 5.2m. CEO: Mark Andree Dekker.
Bankruptcy risk for ASTELLAS PHARMA A/S
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 10888638
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (39 years)
- Address
- Arne Jacobsens Allé 15
2300 København S - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 600k
- Employees
- 80 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 5 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 18.1% |
| Current ratio | 0% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 51 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | DKK 197.9m | DKK 191.0m | DKK 186.9m |
| Gross profit | DKK 22.0m | DKK 24.4m | DKK 20.9m |
| Net profit | DKK 5.2m | DKK 5.7m | DKK 4.5m |
| Equity | DKK 20.1m | DKK 20.8m | DKK 24.7m |
| Total assets | DKK 111.0m | DKK 110.0m | DKK 100.8m |
| Cash | DKK 5.9m | DKK 6.7m | – |
| Short-term debt | DKK 90.9m | DKK 89.1m | – |
| Tax owed | DKK 659k | DKK 819k | – |
| Avg. employees | 0 | 96 | – |
Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Independent Auditor’s Report · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 99 | ||
| 1 Apr 2024 – 31 Mar 2025 | 91 | ||
| 1 Apr 2023 – 31 Mar 2024 | 184 | Late | |
| 1 Apr 2022 – 31 Mar 2023 | 182 | ||
| 1 Apr 2021 – 31 Mar 2022 | 190 | Late | |
| 1 Apr 2020 – 31 Mar 2021 | 156 | ||
| 1 Apr 2019 – 31 Mar 2020 | 164 | ||
| 1 Apr 2018 – 31 Mar 2019 | 152 | ||
| 1 Apr 2017 – 31 Mar 2018 | 143 | ||
| 1 Apr 2016 – 31 Mar 2017 | 153 | ||
| 1 Apr 2015 – 31 Mar 2016 | 152 | ||
| 1 Apr 2014 – 31 Mar 2015 | 104 | ||
| 1 Apr 2013 – 31 Mar 2014 | 150 | ||
| 1 Apr 2012 – 31 Mar 2013 | 152 | ||
| 1 Apr 2011 – 31 Mar 2012 | 145 | ||
| 1 Apr 2010 – 31 Mar 2011 | 152 | ||
| 1 Apr 2009 – 31 Mar 2010 | 132 | ||
| 1 Apr 2008 – 31 Mar 2009 | 180 | ||
| 1 Apr 2007 – 31 Mar 2008 | 164 | ||
| 1 Apr 2006 – 31 Mar 2007 | 152 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mark Andree Dekker | Current | |
| CEO | Per Emil Hasselbalch Stakemann | ||
| CEO | Berend Nico Huisman | ||
| CEO | Stead Arthur Ellis | ||
| CEO | Herman Levinus Pierre Breepoel | ||
| Board | Damla Ebru Atilgan | Current | |
| Board | Mark Andree Dekker | Current | |
| Board | Anne Nymand | Current | |
| Board | Giuseppe Maduri | Current | |
| Board | Ulf Svejgaard Poulsen | ||
| Board | Susanne Saul Stakemann | ||
| Board | Per Emil Hasselbalch Stakemann | ||
| Board | Berend Nico Huisman | ||
| Board | Stead Arthur Ellis | ||
| Board | Arnold Johan Westerveld | ||
| Board | Andre Louis De Haas | ||
| Board | Simon Johannes Quist | ||
| Board | Arend Paasman | ||
| Board | Masakatsu Inoue | ||
| Board | Shigekazu Takahashi | ||
| Board | Henricus Johannes Huiberts | ||
| Board | Philippe Andre Pierre Ballero | ||
| Board | Douwe Wybe Witteveen | ||
| Board | Johannes Adrianus de Heus | ||
| Board | Yasuo Ishii | ||
| Board | Pedro Møllebro | ||
| Board | Wilhelmus Jacques Josephus Kockelkoren | ||
| Board | Herman Levinus Pierre Breepoel | ||
| Board | Gillian Kay Mitchell | ||
| Board | Hiroshi Nogawa | ||
| Board | Mats Stefan Persson | ||
| Board | Seiji Kinoshita | ||
| Board | Nicolaas Jacobus Stander | ||
| Board | Niels Walther-Rasmussen | ||
| Board | Pedro Møllebro | ||
| Board | Jan Anders Martin Nordén | ||
| Board | Pia Terésa Lindkvist | ||
| Board | Yagnaram Santharam | ||
| Board | Malene Abildstrøm | ||
| Board | Karl Håkan Lennart Widen | ||
| Board | Rowena Borenstein | ||
| Board | Morten Auscher | ||
| Owner (100%) | Astellas Pharma Europe LTD. | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | Erik Tronborg Andersen | ||
| Auditor | EY Danmark A/S | ||
| Auditor | CJ Partnership I/S | ||
| Auditor | CJ Partnership I/S | ||
| Auditor | Arthurg Young & Company Intern ational | ||
| Auditor | EY Danmark A/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Founder | ApS HVKMD 5 NR. 555 | Current | |
| Founder | A/S PSE NR. 1285 | Current | |
| Founder | PEHSB ApS | Current |
The CEOs' other companies
Per Emil Hasselbalch Stakemann – 45 other companies, of which 45 bankrupt
- "HEDEVANG MØBLER A/S" Bankrupt 27 Nov 1990
- "J.A.M. TRANSPORTBÅND A/S" Bankrupt 18 Aug 1993
- "NELLE'S RENGØRING A/S" Bankrupt 16 Jul 1990
- 'HG 405 PAVIA AF HIRTSHALS ApS' Bankrupt 4 Jul 2007
- 'ZOO-TEX ApS' Bankrupt 25 Nov 2016
- 02 HOLDING A/S Bankrupt 16 Oct 2008
- 09.28 ANNO 2007 ApS Bankrupt 13 Feb 2009
- 1/7 1987 A/S Bankrupt 21 Aug 2003
- 100 GB ApS Bankrupt 5 May 1994
- 11 DESIGN A/S Bankrupt 28 Apr 2015
- 1356 INVEST ApS Bankrupt 8 Apr 2011
- 15/11 1990 A/S Bankrupt 11 Oct 1994
- 15689382 ApS Bankrupt 26 Jun 2017
- 19.09.2021 ApS Bankrupt 8 Dec 2023
- 23/5 914 ApS Bankrupt 25 Jun 1991
- 3 X 65 SERVICE ApS Bankrupt 3 Mar 1997
- 3 X P A/S Bankrupt 10 Sep 1990
- 31.12.2007 X A/S Bankrupt 28 Oct 2008
- 3B DEVELOPMENT GROUP ApS Bankrupt 2 Nov 2006
- 4 FONTANE ApS Bankrupt 2 Oct 2002
- 4A MANAGEMENT ApS Bankrupt 7 May 1992
- 7 9 13 FORSIKRINGSERVICE ApS Bankrupt 20 Mar 2024
- A - INFORMATIK A/S Bankrupt 9 Oct 2013
- A J J FINANS NR. 1 ApS Bankrupt 23 Feb 1995
- A'SHARQ TV ApS Bankrupt 26 Nov 1992
- A-T SPECIALENTREPRICE ApS Bankrupt 3 Aug 2001
- A. K. OLIE ApS Bankrupt 18 Nov 2008
- A. UNO ApS Bankrupt 19 Jan 1996
- A.B. BYG ApS Bankrupt 4 Dec 1996
- A.H. GRAFIK ApS Bankrupt 23 Jan 1990
Address history (3 moves)
| Arne Jacobsens Allé 15, 2300 København S | |
| Kajakvej 2, 2770 Kastrup | |
| Naverland 4, 2600 Glostrup | |
| Naverland 3, 2600 Glostrup |
Former names
| ASTELLAS PHARMA A/S | – now |
| YAMANOUCHI PHARMA A/S | – |
| BROCADES PHARMA A/S | – |
| GIST-BROCADES PHARMACEUTICALS A/S | – |
| A/S PSE 13 NR. 1079 | – |
Employees per year
Other companies at the same address
- Luxury Yacht Management & Chartering Group ApS Bankrupt
- NOR ApS Bankrupt
- The Yacht Club ApS Bankrupt
- AASTRA TELECOM EUROPE A/S Opløst
- ACCENTURE AUSTRALIA HOLDINGS ApS Opløst
- ACCENTURE DENMARK II ApS Fusioneret
- ACCENTURE TECHNOLOGY SOLUTIONS A/S Fusioneret
- AGFA HEALTHCARE DENMARK A/S Active
- ANPARTSSELSKABET AF 1/3 2008 Active
- AVANADE DENMARK ApS Fusioneret
- ApS Stor-Helsinki Retail Active
- Archimediq ApS Active
- BUBOBUBO A/S Active
- Bonnicksen Holding ApS Active
- CCC Nordic A/S Active
- CLOBE Holding ApS Active
- DNB BALTIC IT A/S Fusioneret
- DNB INVEST DENMARK A/S Active
- DeZignated ApS Active
- Den Røde Tråd I ApS Active
- Ejendomsselskabet Gunnekær ApS Active
- Elcare Nordic A/S Active
- FLOW INVEST ApS Active
- Finsk Invest Holding ApS Active
- HUMANsupport Komplementar ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about ASTELLAS PHARMA A/S
Has ASTELLAS PHARMA A/S gone bankrupt?
No, ASTELLAS PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ASTELLAS PHARMA A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of ASTELLAS PHARMA A/S?
Mark Andree Dekker is the CEO of ASTELLAS PHARMA A/S.
Who is the auditor of ASTELLAS PHARMA A/S?
ASTELLAS PHARMA A/S most recently used EY Godkendt Revisionspartnerselskab.
When was ASTELLAS PHARMA A/S founded?
ASTELLAS PHARMA A/S was founded on 1 July 1987.
What is the equity of ASTELLAS PHARMA A/S?
Equity was DKK 20.1m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.